Sign In
Buy DCPH
$25.59
+0 (+0%)
At Close: Sep 09, 2024
Dublin luxury hotel could face prosecution for removal of "slave" statues
05:05pm, Friday, 07'th Aug 2020
Several complaints were lodged against The Shelbourne Hotel in Dublin after it removed four statues of "slave" girls from its premises on July 27. Dublin City Council accuses the hotel of being in bre
Deciphera Pharmaceuticals, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
12:40pm, Thursday, 06'th Aug 2020
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), today announced that Steve Hoerter, President and Chief Executive Officer, will present at the Canaccord Genuity 40th Annual Growth Conference on Thursda
Deciphera Pharmaceuticals, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
12:00am, Thursday, 06'th Aug 2020
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), today announced that Steve Hoerter, President and Chief Executive Officer, will present at the Canaccor
Deciphera Pharmaceuticals, Inc. (DCPH) Q2 2020 Earnings Call Transcript
12:01pm, Wednesday, 05'th Aug 2020
DCPH earnings call for the period ending June 30, 2020.
Deciphera Pharmaceuticals (NASDAQ:DCPH) Raised to “Buy” at ValuEngine
07:42am, Wednesday, 05'th Aug 2020
Deciphera Pharmaceuticals (NASDAQ:DCPH) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q2 Loss, Tops Revenue Estimates
10:25pm, Tuesday, 04'th Aug 2020
Deciphera Pharmaceuticals, Inc. (DCPH) delivered earnings and revenue surprises of 10.45% and 249.26%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for t
Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2020 Financial Results
08:05pm, Tuesday, 04'th Aug 2020
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced financial results for the second quarter ended June 30, 2020 and provided an update on clinical and corporate developments.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 4, 2020
11:00am, Wednesday, 29'th Jul 2020
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced that it will report its second quarter 2020 financial results on Tuesday, August 4, 2020.
ASX queries DigitalX over share price and volume increase - FinanceFeeds
06:32am, Monday, 27'th Jul 2020
The company insists that it is in compliance with the Listing Rules.
£10k to invest? I think these FTSE 100 stocks could make you rich
10:10am, Sunday, 26'th Jul 2020
If you have £10k or any other amount to invest today, buying these 2 FTSE 100 stocks that are profiting from large tailwinds could be a great decision.
China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor
02:39pm, Monday, 20'th Jul 2020
Zai Lab Limited (NASDAQ: ZLAB) and Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that the China National Medical Products Administration (NMPA) has accepted its New Drug Application (
Resellers' inability to access customer sites hampers B2B sales at Exertis parent
02:11pm, Monday, 20'th Jul 2020
Although DCC Group stresses that it is pleased with trading across its four arms
